Condition
Hormone Refractory Prostate Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Hormone Refractory Prostate Cancer clinical trials that are recruiting, at sites in 4 countries (most in United States (2), Australia (1), Spain (1)). By phase: Phase 1 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 4Countries
All recruiting trials (2)
-
SHY-ONC6: a new anti-cancer drug tested in adults with advanced solid tumors
This early-phase study tests SHY-ONC6 to see if it is safe and can help people with advanced solid tumors after standard therapies have failed.
-
Evaluating AMX-500 for advanced prostate cancer
This study is testing a new drug called AMX-500 to see if it is safe and effective for people with advanced prostate cancer that has spread and doesn't respond to hormone treatment.
Related topics
Quick answers
How many Hormone Refractory Prostate Cancer clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (2 trials), Australia (1 trial), Spain (1 trial), United Kingdom (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.